COLL vs DVA · P/E 17, rev $181.9M vs P/E 14, rev $12.82B
Collegium Pharmaceutical Inc (COLL) versus DaVita HealthCare Partners Inc (DVA) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Not investment advice. Open the COLL and DVA stock pages for the full models.
Not investment advice.